Exane Derivatives’s Copart CPRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$326 Hold
12
﹤0.01% 625
2022
Q1
$376 Hold
12
﹤0.01% 900
2021
Q4
$455 Hold
12
﹤0.01% 777
2021
Q3
$416 Hold
12
﹤0.01% 958
2021
Q2
$415 Hold
12
﹤0.01% 963
2021
Q1
$326 Sell
12
-15,324
-100% -$432K ﹤0.01% 836
2020
Q4
$488K Buy
15,336
+15,308
+54,671% +$446K 0.14% 161
2020
Q3
$736 Hold
28
﹤0.01% 648
2020
Q2
$583 Hold
28
﹤0.01% 601
2020
Q1
$480 Sell
28
-26,608
-100% -$592K ﹤0.01% 599
2019
Q4
$644K Buy
+26,636
New +$569K 0.12% 138

Other funds holding CPRT

Exane Derivatives's CPRT Position: Q2 2022 in Review

Exane Derivatives held its Copart (CPRT) position steady in Q2 2022 at 12 shares worth $326. The position accounts for ﹤0.01% of the portfolio, ranked #625.

Exane Derivatives first reported a position in CPRT in Q4 2019 and has held it in 11 quarters since. The position peaked at $644K in Q4 2019. 822 funds tracked by Wall St. Rank hold CPRT as of Q2 2022.

  • Exane Derivatives held 12 shares of Copart worth $326 as of Q2 2022.
  • Exane Derivatives left its Copart share count unchanged in Q2 2022.
  • Copart made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #625 holding.
  • Exane Derivatives first reported a position in Copart in Q4 2019 and has held it in 11 quarters since.
  • Exane Derivatives's Copart position peaked at $644K in Q4 2019.
  • 822 funds tracked by Wall St. Rank held Copart as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.